HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniel V LaBarbera Selected Research

glucogallin

6/2015Aldose reductase inhibition alleviates hyperglycemic effects on human retinal pigment epithelial cells.
1/2012The isolation and characterization of β-glucogallin as a novel aldose reductase inhibitor from Emblica officinalis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daniel V LaBarbera Research Topics

Disease

12Neoplasms (Cancer)
04/2024 - 07/2009
3Neoplasm Metastasis (Metastasis)
12/2023 - 02/2011
3Thyroid Neoplasms (Thyroid Cancer)
09/2022 - 01/2018
2Colorectal Neoplasms (Colorectal Cancer)
12/2023 - 11/2019
2Urinary Bladder Neoplasms (Bladder Cancer)
09/2022 - 01/2021
2Diabetes Complications
01/2018 - 01/2012
2Cataract (Cataracts)
01/2016 - 01/2012
2Breast Neoplasms (Breast Cancer)
10/2012 - 02/2011
1Melanoma (Melanoma, Malignant)
09/2022
1Glioblastoma (Glioblastoma Multiforme)
09/2022
1Atherosclerosis
01/2020
1Vascular Remodeling
01/2020
1Vascular Diseases (Vascular Disease)
01/2020
1Inflammation (Inflammations)
01/2020
1follicular Thyroid cancer
01/2019
1Pleural Effusion (Pleural Effusions)
01/2019
1Papillary Thyroid Cancer
01/2019
1Anaplastic Thyroid Carcinoma
01/2019
1Type 2 Diabetes Mellitus (MODY)
01/2018
1Hyperglycemia
06/2015
1Eye Diseases (Eye Disease)
01/2014
1Tuberculosis (Tuberculoses)
09/2006

Drug/Important Bio-Agent (IBA)

3Antineoplastic Agents (Antineoplastics)IBA
10/2022 - 07/2009
3Aldehyde Reductase (Aldose Reductase)IBA
01/2018 - 01/2012
2DNA HelicasesIBA
12/2023 - 10/2022
2Carrier Proteins (Binding Protein)IBA
12/2023 - 10/2022
2EnzymesIBA
12/2023 - 01/2018
2Telomerase (Telomerase Reverse Transcriptase)IBA
09/2022 - 01/2021
2glucogallinIBA
06/2015 - 01/2012
2LuciferasesIBA
10/2012 - 02/2011
1Phosphotransferases (Kinase)IBA
09/2022
1Azacitidine (5 Azacytidine)FDA Link
01/2020
1Contractile ProteinsIBA
01/2020
1Angiotensin IIIBA
01/2020
1PTEN Phosphohydrolase (PTEN Phosphatase)IBA
01/2020
1TensinsIBA
01/2020
1TCF Transcription FactorsIBA
11/2019
1RacivirIBA
01/2019
1CarbohydratesIBA
01/2018
1CytidineIBA
01/2018
1lenvatinibIBA
01/2018
1Glucose (Dextrose)FDA LinkGeneric
01/2016
1Emodin (Archin)IBA
01/2016
1polyolIBA
01/2016
1Retinal Pigments (Pigments, Visual)IBA
06/2015
1AmidesIBA
01/2014
1GlucosidesIBA
01/2014
1Phenobarbital (Luminal)FDA Link
10/2012
1Progestins (Progestagens)IBA
10/2012
1ProgesteroneFDA LinkGeneric
10/2012
1Hormones (Hormone)IBA
10/2012
1Estrogens (Estrogen)FDA Link
10/2012
1Green Fluorescent ProteinsIBA
10/2012
1Keratin-5 (Keratin 5)IBA
10/2012
1Biomarkers (Surrogate Marker)IBA
02/2011
1VimentinIBA
02/2011
1neoamphimedineIBA
01/2011
1Type I DNA Topoisomerases (Topoisomerase I)IBA
01/2011
1AlkaloidsIBA
07/2009
1naamidine AIBA
07/2009
1Caspase 3 (Caspase-3)IBA
07/2009
1pseudodestruxin CIBA
09/2006
1DepsipeptidesIBA
09/2006
1destruxin EIBA
09/2006

Therapy/Procedure

9Therapeutics
04/2024 - 02/2011
2Drug Therapy (Chemotherapy)
11/2019 - 10/2012
1Precision Medicine
09/2022
1Oral Administration
01/2016
1Lenses
01/2016